Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2011 2
2012 1
2015 1
2016 1
2017 4
2018 6
2019 2
2020 6
2021 3
2022 3
2023 1
2024 5
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
The expanded French compassionate programme for elexacaftor-tezacaftor-ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study.
Burgel PR, Sermet-Gaudelus I, Girodon E, Durieu I, Houdouin V, Audousset C, Macey J, Grenet D, Porzio M, Murris-Espin M, Reix P, Baravalle M, Belleguic C, Mely L, Verhille J, Weiss L, Reynaud-Gaubert M, Mittaine M, Hamidfar R, Ramel S, Cosson L, Douvry B, Danner-Boucher I, Foucaud P, Roy C, Burnet E, Raynal C, Audrezet MP, Da Silva J, Martin C; French Cystic Fibrosis Reference Network study group. Burgel PR, et al. Lancet Respir Med. 2024 Nov;12(11):888-900. doi: 10.1016/S2213-2600(24)00208-X. Epub 2024 Aug 13. Lancet Respir Med. 2024. PMID: 39151434
A rare carcinoma of the parotid.
El Amine El Hadj O, Gabsi A, Gritli S, El May A. El Amine El Hadj O, et al. Among authors: gabsi a. Eur Ann Otorhinolaryngol Head Neck Dis. 2016 Feb;133(1):63-4. doi: 10.1016/j.anorl.2015.08.011. Epub 2016 Jan 5. Eur Ann Otorhinolaryngol Head Neck Dis. 2016. PMID: 26778446 Free article. No abstract available.
Elexacaftor/Tezacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients With Cystic Fibrosis.
Truong NH, Benaboud S, Bouazza N, Barboura M, Bardin E, Miralles M, Lui G, Froelicher-Bournaud L, Rouillon S, Bihouee T, Bui S, Reix P, Dalphin ML, Laurans M, Languepin J, Corvol H, Troussier F, Weiss L, Cinthia R, Tatopoulos A, Deneuville E, Chiron R, Stremler N, Llerena C, Ramel S, Perisson C, Houdoin V, Mittaine M, Treluyer JM, Sermet-Gaudelus I, Foissac F; MODUL‐CF study group. Truong NH, et al. Clin Transl Sci. 2025 May;18(5):e70245. doi: 10.1111/cts.70245. Clin Transl Sci. 2025. PMID: 40347054 Free PMC article.
Impact of elexacaftor/tezacaftor/ivacaftor on glucose tolerance in adolescents with cystic fibrosis.
Galderisi A, Weiss L, Besançon A, Stremler N, Reix P, Wizla N, Lustre A, Rames C, Tatopoulos A, Perisson C, Dalphin ML, Troussier F, Houdouin V, Bessaci K, Cosson L, Gabsi A, Corvol H, Deneuville E, Storni V, Ramel S, Bui S, Heraud MC, Remus N, Huet F, Scalbert M, Mely L, Gachelin E, Giannantonio M, Letierce A, Sahki D, Marguet C, Bonnel AS, Sermet-Gaudelus I; MODUL CF group. Galderisi A, et al. Among authors: gabsi a. J Clin Endocrinol Metab. 2025 Feb 20:dgaf099. doi: 10.1210/clinem/dgaf099. Online ahead of print. J Clin Endocrinol Metab. 2025. PMID: 39977216
Gastric EBV-positive mucocutaneous ulcer: A rare pathological entity.
Gabsi A, Zenzri Y, Sahraoui G, Ben Brahim I, Cherif M, Yahyaoui Y, Chraiet N, Mrad K, Chedly A, Ben Maamer A, Mezlini A. Gabsi A, et al. Clin Case Rep. 2020 Apr 13;8(7):1130-1133. doi: 10.1002/ccr3.2837. eCollection 2020 Jul. Clin Case Rep. 2020. PMID: 32695342 Free PMC article.
36 results